Alcon Laboratories (U.K) Limited

Pentagon Park, Boundary Way, Hemel Hempstead, Hertfordshire, HP2 7UD
Telephone: +44 (0)1442 341 234
Fax: +44 (0)1442 341 200

Summary of Product Characteristics last updated on the eMC: 22/03/2002
SPC Isopto Alkaline


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

ISOPTO ALKALINE


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Hypromellose 1.0% w/v


Go to top of the page
3. PHARMACEUTICAL FORM

Eye drops, solution.


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Used topically to provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production. (Usually in cases of rheumatoid arthritis, keratoconjunctivitis sicca and xerophthalmia).

Also used as an ocular lubricant for artificial eyes.


Go to top of the page
4.2 Posology and method of administration

Adults, children and the elderly:

The dose depends on the need for lubrication. Usually one to two drops to each eye three times daily or as prescribed.


Go to top of the page
4.3 Contraindications

Hypersensitivity to any component of the product. The product contains benzalkonium chloride and should not be used when soft contact lenses are worn.


Go to top of the page
4.4 Special warnings and precautions for use

If irritation persists or worsens, or headache, eye pain, vision changes or continued redness occur, discontinue use and consult a physician.

To preserve sterility do not allow the dropper to touch the eye or any other surface.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

None known


Go to top of the page
4.6 Pregnancy and lactation

There is insufficient evidence as to safety in pregnancy and this product should, therefore, only be used in pregnancy if it is considered essential by the physician.


Go to top of the page
4.7 Effects on ability to drive and use machines

May cause transient blurring of vision on instillation. Do not drive or operate hazardous machinery unless vision is clear.


Go to top of the page
4.8 Undesirable effects

May cause transient mild stinging or temporarily blurred vision.


Go to top of the page
4.9 Overdose

Not applicable


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

OPHTHALMOLOGICALS: OTHER OPHTHALMOLOGICALS:

ATC CODE: SO1X A20


Go to top of the page
5.1 Pharmacodynamic properties

Hypromellose is an inert substance. It has no pharmacological activity.


Go to top of the page
5.2 Pharmacokinetic properties

Hypromellose is an inert substance. It has no pharmacological activity and, hence, the pharmacokinetic properties have not been studied.


Go to top of the page
5.3 Preclinical safety data

There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the SPC.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Sodium citrate dihydrate , Disodium Phosphate anhydrous,

Sodium biphosphate , Sodium chloride , Benzalkonium chloride, Purified water.


Go to top of the page
6.2 Incompatibilities

None known


Go to top of the page
6.3 Shelf life

36 months (unopened), 1 month (after first opening).


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C. Do not refrigerate.

Keep container tightly closed.

Discard 1 month after opening.


Go to top of the page
6.5 Nature and contents of container

10 mL Drop-Tainer - Natural Low Density Polyethylene Bottle and Plug.

Polystyrene or Polypropylene cap.


Go to top of the page
6.6 Special precautions for disposal and other handling

Do not touch dropper tip to any surface as this may contaminate the contents.

If the drop of medication is not retained in the eye upon dosing for any reason, instil another drop.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

Alcon Laboratories (UK) Ltd.,

Pentagon Park,

Boundary Way,

Hemel Hempstead,

HP2 7UD.


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PL 0649/5900R


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

9th October 1990/18th December 2001


Go to top of the page
10. DATE OF REVISION OF THE TEXT

January 2002



More information about this product

Link to this document from your website: http://emc.medicines.org.uk/medicine/62/SPC/Isopto Alkaline/


Active Ingredients/Generics

 
   hydroxypropylmethyl cellulose
   hypromellose


© 2010 Datapharm Communications Ltd

Go to www.medicines.org.uk